Neuroprotective effects of erythropoietin in patients with severe closed brain injury

Turkish Neurosurgery

Volumn 25, Issue 4, 2015, Pages 552-558

  Aloizos, Stavros ^a   Evodia, Efimia ^b   Gourgiotis, Stavros ^a   Isaia, Eleni Christina ^a   Seretis, Charalampos ^a   Baltopoulos, George J ^b  

^a 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Brain; Erythropoietin; Injury; Mortality; Outcome

Indexed keywords

ERYTHROPOIETIN; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN; VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; AGED; APACHE; BRAIN INJURIES; COHORT ANALYSIS; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEAD INJURIES, CLOSED; HUMAN; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APACHE; BRAIN INJURIES; COHORT STUDIES; ERYTHROPOIETIN; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEAD INJURIES, CLOSED; HUMANS; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROGNOSIS; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84938342141     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.JTN.9685-14.4     Document Type: Article

References (41)

1. Adams JH, Jennett B, Murray LS, Teasdale GM, Gennarelli TA, Graham DI: Neuropathological findings in disabled survivors of a head injury. J Neurotrauma 28:701-709, 2011
2. Banerjee D, Rodriguez M, Naq M, Adamson JW: Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int 57:1895-1904, 2000
3. Bouzat P, Francony G, Thomas S, Valable S, Mauconduit F, Fevre MC, Barbier EL, Bernaudin M, Lahrech H, Payen JF: Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative. Crit Care Med 39:2099-2105, 2011
4. Brines M, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A: Erythropoietin crosses the bloodbrain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97:10526-10531, 2000
5. Campana WM, Misasi R, O'Brien JS: Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1:235-241, 1998
6. Carey ME: Analysis of wounds incurred by US Army Seventh Corps personnel treated in Corps hospitals during Operation Desert Storm, February 20 to March 10, 1991. J Trauma 40 Suppl 3:S165-S169, 1996
7. Casadevall N: Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin. Nephrol Dial Transplant 18:viii37-viii41, 2003
8. Coleman T, Brines M: Science review: Recombinant human erythropoietin in critical illness: A role beyond anemia? Crit Care 8:337-341, 2004
9. CRASH Trial Collaborators: Final results of MRC CRASH, a randomized placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 365:1957-1959, 2005
10. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Rüther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Sirén AL: Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505, 2002
11. FDA Safety Information and Adverse Event Reporting Program: Aranesp (darbepoetin alfa). In: Safety alerts for human medical products. FDA. Available via MedWatch. http://www.fda.gov/medwatch/safety/2005/Epogen_PI_10-26-05.pdf. Accessed Jan 12, 2005
12. Feeser VR, Loria RM: Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. J Neuroimmunol 237:4-12, 2011
13. Genc S, Akhisaroglu M, Kuralay F, Genc K: Erythropoietin restores glutathione peroxidase activity in 1-methyl-4- phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett 321:73-76, 2002
14. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, Brines M: Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99:9450-9455, 2002
15. Grasso G: Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 45:7-14, 2001
16. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De Vico G, Piedimonte G, Salpietro FM, Tomasello F: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 99:5627-5631, 2002
17. Grasso G, Sfacteria A, Cerami A, Brines M: Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 10:93-98, 2004
18. Grasso G, Sfacteria A, Erbayraktar S, Passalacqua M, Meli F, Gokmen N, Yilmaz O, La Torre D, Buemi M, Iacopino DG, Coleman T, Cerami A, Brines M, Tomasello F: Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine 4:310-318, 2006
19. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A: A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics 118:180-188, 2006
20. Juul SE, McPherson RJ, Farrell FX, Jolliffe L, Ness DJ, Gleason CA: Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate 85:138-144, 2004
21. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M: Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 276:39469-39475, 2001
22. Kellert BA, McPherson RJ, Juul SE: A comparison of high-dose recombinant erythropoietin treatment regimens in braininjured neonatal rats. Pediatr Res 61:451-455, 2007
23. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, Kiray M, Genc S, Duman N, Koroglu TF, Ozkan H, Genc K: Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 153:77-86, 2004
24. Langlois JA, Marr A, Mitchko J, Johnson RL: Tracking the silent epidemic and educating the public: CDC's traumatic brain injury-associated activities under the TBI Act of 1996 and the Children's Health Act of 2000. J Head Trauma Rehabil 20:196-204, 2005
25. Liao ZB, Zhi XG, Shi QH, He ZH: Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur J Neurol 15:140-149, 2008
26. Lu D, Mahmood A, Qu C, Goussev A, Schallert T, Chopp M: Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22:1011-1017, 2005
27. Nirula R, Kaufman R, Tencer A: Traumatic brain injury and automotive design: Making motor vehicles safer. J Trauma 55:844-848, 2003
28. Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor JR: Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 56:60-71, 1999
29. Sander AM, Caroselli JS, High WM Jr, Becker C, Neese L, Scheibel R: Relationship of family functioning to progress in a post-acute rehabilitation programme following traumatic brain injury. Brain Inj 16:649-657, 2002
30. Shein NA, Horowitz M, Alexandrovich AG, Tsenter J, Shohami E: Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab 25:1456-1465, 2005
31. Sirén AL, Radyushkin K, Boretius S, Kämmer D, Riechers CC, Natt O, Sargin D, Watanabe T, Sperling S, Michaelis T, Price J, Meyer B, Frahm J, Ehrenreich H: Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 129:480-489, 2006
32. Soustiel JF, Palzur E, Nevo O, Thaler I, Vlodavsky E: Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J Neurotrauma 22:345-352, 2005
33. Springborg JB, Ma X, Rochat P, Knudsen GM, Amtorp O, Paulson OB, Juhler M, Olsen NV: A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 135:823-829, 2005
34. Statler PA, McPherson, RJ, Bauer LA, Kellert BA, Juul SE: Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 61:1-15, 2007
35. Sun Y, Calvert JW, Zhang JH: Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36:1672-1678, 2005
36. Tsukahara H, Hiraoka M, Hori C, Hata I, Okada T, Gejyo F, Sudo M: Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats. Scand J Clin Lab Invest 57:487-493, 1997
37. Ulusal I, Tari R, Ozturk G, Aycicek E, Aktar F, Kotil K, Bilge T, Kiriş T: Dose-dependent ultrastructural and morphometric alterations after erythropoietin treatment in rat femoral artery vasospasm model. Acta Neurochir (Wien) 152: 2161-2166, 2010
38. Vairano M, Dello Russo C, Pozzoli G, Battaglia A, Scambia G, Tringali G, Aloe-Spiriti MA, Preziosi P, Navarra P: Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 16:584-592, 2002
39. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975, 2003
40. Wagner AK: TBI translational rehabilitation research in the 21st Century: Exploring a Rehabilomics research model. Eur J Phys Rehabil Med 46:549-556, 2010
41. Wu XC, Richards NT, Johns EJ: Role of erythropoietin and nitric oxide in modulating the tone of human renal interlobular and subcutaneous arteries from uraemic subjects. Clin Sci (Lond) 97:639-647, 1999